Success Stories: We Supported a Research Professional Attain O1-A Approval from India in Just 13 Days, Thanks to Premium Processing
Client’s Testimonial:
"Thank you very much for your support and help in filing my O-1 visa application.”
On December 29th, 2020, we received another O1-A (Individual with extraordinary ability or achievement) approval for a Research Professional in the Field of Personalized Medicine (Approval Notice).
General Field: Personalized Medicine
Position at the Time of Case Filing: Research Professional
Country of Origin: India
Approval Notice Date: December 29th, 2020
Processing Time: 13 days (Premium Processing Requested)
Case Summary:
North America Immigration Law Group (NAILG) was approached by a research professional to help him secure an O1-A (Individuals with Extraordinary Ability or Achievement) visa.
He was obliged to show that he was an individual with extraordinary ability to continue work in his area of specialization in the U.S. We supported him in every possible way, and he achieved this goal and secured petition approval in just 13 days. Our comprehensive experience dealing with employment-based visa petitions equipped us with the sound legal strategy to secure our client’s O1A petition approval.
Before we originated his case, we administered his credentials to confirm his chances of O1-A approval. We fortified that he held a Ph.D. in biosciences and bioengineering and his research focusing on cancer biomarkers and cancer detection. We successfully concluded that our client’s research addresses some of our nation’s most pressing issues in understanding essential biomarkers for new diagnostic tests for cancer. Our purpose was to demonstrate to the USCIS that our client’s research is of great importance to the United States.
We detailed our client’s citation and publication record in his O1A petition dossier. At the time of filing, our client’s publications comprised 11 peer-reviewed journal articles and 2 book chapters that had amassed 175 citations. Besides, our client has reviewed 160 times for highly acclaimed journals in the field of personalized medicine. Only well-knowledgeable experts in their field are encouraged to perform this type of important editorial work, which demonstrates our client’s prominent standing in the field.
To validate his expertise and the importance of his research, we attached 5 written advisory opinions from experts in the field vouching to the importance and significance of our client’s contributions. One of the letters had the below-mentioned excerpt:
“[Our client’s] caliber and ability are truly rare, and that his ability to continue his work without interruption represents the best case scenario not only for the field but also for the millions of patients worldwide who stand to benefit from his work.”
Finally, we were able to demonstrate our client’s case to the USCIS that had satisfied the O1A standards. We congratulate him for acquiring O1-A petition approval and we also thank him for having faith in us for representing his O1-A application.